218 results on '"Fransen, Marieke F"'
Search Results
2. Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors
3. Preclinical Identification Of Tumor-Draining Lymph Nodes Using a Multimodal Non-invasive In vivo Imaging Approach
4. Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis
5. Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC
6. Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies
7. Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis
8. Supplementary Figures from A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
9. Data from A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
10. Supplementary Tables from A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
11. A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
12. CD40 Stimulation Leads to Effective Therapy of CD40- Tumors through Induction of Strong Systemic Cytotoxic T Lymphocyte Immunity
13. Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment
14. Predictive value of Combined Positive Score (CPS) and Tumor Proportion Score (TPS) for immunotherapy response in advanced Non-Small Cell Lung Cancer (NSCLC)
15. Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors
16. Supplementary Figure 2 from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
17. CCR Translation for This Article from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
18. Supplementary Figure Legend from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
19. Supplementary Figure 1 from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
20. Supplementary Figure 3 from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
21. Supplementary figures S1-S5 from Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy
22. Supplementary table 1 and 2 from Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy
23. Supplementary Figures S1-S3 from Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
24. Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation
25. Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancer
26. Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic T reg reduction and effector T cell activation
27. Immunological Responses to Cancer Therapy
28. Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy
29. Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model
30. Genome-wide cell-free DNA termini in patients with cancer
31. Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
32. Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model
33. Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation.
34. Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy
35. Local targets for immune therapy to cancer: Tumor draining lymph nodes and tumor microenvironment
36. CD40 stimulation leads to effective therapy of CD[40.sup.-] tumors through induction of strong systemic cytotoxic T lymphocyte immunity
37. Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy
38. Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
39. Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy.
40. Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering
41. FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model
42. Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering
43. Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering
44. A Dual-Color Bioluminescence Reporter Mouse for Simultaneous in vivo Imaging of T Cell Localization and Function
45. A Restricted Role for FcγR in the Regulation of Adaptive Immunity
46. Functional diversification of hybridoma produced antibodies by CRISPR/HDR genomic engineering
47. A Dual-Color Bioluminescence Reporter Mouse for Simultaneous in vivo Imaging of T Cell Localization and Function
48. High FcγR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody Therapy
49. Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy
50. Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.